perindopril has been researched along with nitrates in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartosz, G; Czuczejko, J; Kedziora, J; Kedziora-Kornatowska, K; Kornatowski, T; Pawluk, H; Szadujkis-Szadurski, L | 1 |
Czuczejko, J; Kedziora, J; Kedziora-Kornatowska, K; Kornatowski, T; Motyl, J; Pawluk, H; Szadujkis-Szadurski, L; Szewczyk-Golec, K | 1 |
Bachetti, T; Bastianon, D; Cargnoni, A; Ceconi, C; Comini, L; Ferrari, R; Gitti, GL | 1 |
Al-Qubaisi, M; Hakim, MN; Hussein Al Ali, SH; Hussein, MZ; Ismail, M; Zainal, Z | 1 |
1 trial(s) available for perindopril and nitrates
Article | Year |
---|---|
Effects of perindopril and hydrochlorothiazide on selected indices of oxidative stress in the blood of elderly patients with essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Catalase; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Malondialdehyde; Nitrates; Nitrites; Oxidative Stress; Perindopril; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
3 other study(ies) available for perindopril and nitrates
Article | Year |
---|---|
Production of nitric oxide, lipid peroxidation and oxidase activity of ceruloplasmin in blood of elderly patients with primary hypertension. Effects of perindopril treatment.
Topics: Adult; Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Ceruloplasmin; Humans; Hypertension; Lipid Peroxidation; Malondialdehyde; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Perindopril; Renin-Angiotensin System | 2006 |
Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Enalapril; Immunoblotting; Indoles; Male; Myocytes, Cardiac; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Perindopril; Quinapril; Ramipril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines | 2007 |
Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.
Topics: Aluminum Compounds; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Stability; Hepatocytes; Humans; Intercalating Agents; Metal Nanoparticles; Microscopy, Electron, Scanning; Models, Molecular; Nanocomposites; Nanomedicine; Nitrates; Perindopril; Powder Diffraction; Spectroscopy, Fourier Transform Infrared; Surface Properties; Zinc | 2012 |